Group One Trading’s Neurotrope, Inc. Common NTRP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-9,037
Closed -$11.3K 6449
2020
Q1
$7K Sell
9,037
-29,421
-77% -$32.1K ﹤0.01% 4711
2019
Q4
$38K Sell
38,458
-65,401
-63% -$51K ﹤0.01% 4133
2019
Q3
$84K Buy
103,859
+95,203
+1,100% +$437K ﹤0.01% 3677
2019
Q2
$69K Buy
+8,656
New +$58.2K ﹤0.01% 3600
2018
Q1
Sell
-6,484
Closed -$51.5K 5535
2017
Q4
$46K Sell
6,484
-15,171
-70% -$88.4K ﹤0.01% 3777
2017
Q3
$112K Sell
21,655
-2,000
-8% -$10.5K ﹤0.01% 3166
2017
Q2
$222K Buy
+23,655
New +$253K ﹤0.01% 2574

Other funds holding NTRP

Group One Trading's NTRP Position: Q2 2020 in Review

Group One Trading sold out of Neurotrope, Inc. Common (NTRP) in Q2 2020, closing a stake of 9,037 shares — an estimated $11.3K sold.

Group One Trading first reported a position in NTRP in Q2 2017 and held it in 7 quarters. The position peaked at $222K in Q2 2017. 31 funds tracked by Wall St. Rank hold NTRP as of Q2 2020.

  • Group One Trading reported no remaining Neurotrope, Inc. Common position as of Q2 2020 after selling out during the quarter.
  • Group One Trading sold 9,037 Neurotrope, Inc. Common shares in Q2 2020, an estimated $11.3K.
  • Group One Trading first reported a position in Neurotrope, Inc. Common in Q2 2017 and held it in 7 quarters.
  • Group One Trading's Neurotrope, Inc. Common position peaked at $222K in Q2 2017.
  • 31 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q2 2020.

Based on Group One Trading's 13F filing for Q2 2020, filed 13 Aug 2020.